Showing results (341-350 of 367) with videos related to
Sort By:
Pageof 37
American Journal of Pharmaceutical Education|December 14, 2024
Pioneering Computational Culture Within Pharmacy Schools by Empowering Students With Data Science and Bioinformatics SkillsCynthia Ronkowski, Dhrithi Deshpande, Nitesh Sharma, et al.Mayo Clinic Proceedings|October 18, 2019
Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney DiseaseYao Qiao, Jung-Im Shin, Yingying Sang, et al.Journal of General Internal Medicine|June 30, 2025
US Public Health Gains from Improved Treatment of Hypercholesterolemia: A Simulation Study of NHANES Adults Treated to Guideline-Directed TherapyG Caleb Alexander, Jill Curran, Alejandro Victores, et al.BMJ Open|December 29, 2022
Drug-drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case-control study in the National COVID Cohort Collaborative (N3C)Olga V Kravchenko, Richard D Boyce, Ainhoa Gomez-Lumbreras, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 27, 2024
Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 SeverityKlara R Klein, Trine J Abrahamsen, Anna R Kahkoska, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2021
Real-World Effectiveness of Remdesivir in Adults Hospitalized With Coronavirus Disease 2019 (COVID-19): A Retrospective, Multicenter Comparative Effectiveness StudyBrian T Garibaldi, Kunbo Wang, Matthew L Robinson, et al.Medical Care|October 18, 2024
Hospital-Level Variation in COVID-19 Treatment Among Hospitalized Adults in the United States: A Retrospective Cohort StudyG Caleb Alexander, Brian T Garibaldi, Huijun An, et al.JAMA Network Open|January 16, 2019
Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial InsurersDora H Lin, Christopher M Jones, Wilson M Compton, et al.Diabetes Care|June 17, 2021
Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 OutcomesAnna R Kahkoska, Trine Julie Abrahamsen, G Caleb Alexander, et al.AIDS (London, England)|June 12, 2024
Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIVY Joseph Hwang, Catherine R Lesko, Todd T Brown, et al.Pageof 37